An Open Label Study of Oral Enzastaurin in Participants With Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Clinical Trials Related to Cancer
Related studies linked through entity extraction aliases.
Ixabepilone Administered as an Enteric Coated Formulation.
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Food Upon Pharmacokinetics of Single Oral Dose of Cediranib (AZD2171, Recentin™)
- Status
- COMPLETED
- Phase
- PHASE2
A Study of PROCRIT (Epoetin Alfa) 80,000 Units (U) Once Every Four Weeks (Q4W) vs. 40,000 U Once Every Two Weeks (Q2W) in Cancer Patients Not Receiving Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Study of NGR-hTNF in Combination With Doxorubicin in Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Prophylaxis of Venous Thrombo-Embolism in Cancer Patients Under Palliative Care
- Status
- TERMINATED
- Phase
- N/A
ARQ 197 in Subjects With Metastatic Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Home-Based Symptom Monitoring: Its Impact on Cancer Care Team Behaviors and Patient Outcomes
- Status
- UNKNOWN
- Phase
- N/A
Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Psychological Interventions in Siblings of Children With Cancer
- Status
- COMPLETED
- Phase
- NA
Study of BEMA™ Fentanyl in the Treatment of Breakthrough Pain in Cancer Subjects
- Status
- COMPLETED
- Phase
- PHASE3
Study of the Safety of BEMA™ Fentanyl Use for Breakthrough Pain in Cancer Subjects on Chronic Opioid Therapy
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability and Maximum Tolerated Dose of Oral AP23573 in Combination With Doxorubicin (8669-015)
- Status
- COMPLETED
- Phase
- PHASE1
Determination of Amifostine Levels During Radiation Therapy
- Status
- COMPLETED
- Phase
- N/A
Quality of Life Among Children and Adolescents With Cancer
- Status
- WITHDRAWN
- Phase
- N/A
Comparison of Delta-8-THC to Ondansetron in the Prevention of Acute Nausea From Moderately Emetogenic Chemotherapy
- Status
- TERMINATED
- Phase
- PHASE2
Phase I Study of MEDI522 in Patients With Irinotecan-Refractory Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
- Status
- TERMINATED
- Phase
- N/A
A Dose and Schedule Finding Trial With AMG 531 for Chemotherapy Induced Thrombocytopenia (CIT) in Adults With Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2